Department of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Department of Pediatrics, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
J Diabetes. 2022 Sep;14(9):571-585. doi: 10.1111/1753-0407.13309. Epub 2022 Sep 4.
Advanced glycation end products (AGEs) that abnormally accumulate in diabetic patients have been reported to damage bone health. We aimed to investigate the association between skin autofluorescence (SAF)-AGE (SAF - AGEs × age/100) and low bone density (LBD)/osteoporosis or major osteoporotic fractures (MOFs) in patients with type 2 diabetes mellitus (T2DM).
This study was nested in the prospective REACTION (Risk Evaluation of Cancers in Chinese Diabetic Individuals) study and included 1214 eligible participants. SAF was used to measure skin AGEs (SAF-AGEs). Fracture events were determined by an in-person clinical follow-up. Binary logistic regression analysis, linear regression analysis, and a restricted cubic spline nested in logistic models were used to test outcomes.
The overall prevalence of LBD/osteoporosis in middle-aged or elderly T2DM patients was 35.7% (n = 434), and the overall incidence of MOFs was 10.5% (n = 116). Logistic analysis showed a significantly positive relationship between quartiles of SAF-AGE and the risk of LBD/osteoporosis (odds ratio [OR] 2.02, 95% CI 1.34-3.03; OR 3.63, CI 2.44-5.39; and OR 6.51, CI 4.34-9.78) for the multivariate-adjusted models, respectively. SAF-AGE was associated with MOFs with a multivariate-adjusted OR of 1.02 (CI 0.52-2.02), 2.42 (CI 1.32-4.46), and 2.70 (CI 1.48-4.91), respectively. Stratified analyses showed that SAF-AGE was significantly associated with MOFs only in females, nonsmokers, nondrinkers, individuals with lower body mass index, and those without LBD/osteoporosis. Linear regression analyses showed that higher SAF-AGEs were associated with a higher level of serum N-terminal propeptide of type I procollagen (s-PINP) and serum carboxy-terminal cross-linking peptide of type I collagen (s-CTX), with a multivariate-adjusted OR of 1.02 (CI 0.24-1.80) and 6.30 (CI 1.77-10.83), respectively.
In conclusion, SAF-AGE was positively associated with the prevalence of LBD/osteoporosis or MOFs in patients with T2DM. A positive association between SAF-AGEs and the level of s-PINP and s-CTX was found.
已有研究报道,糖尿病患者体内异常堆积的晚期糖基化终产物(AGEs)会损害骨骼健康。本研究旨在探讨 2 型糖尿病(T2DM)患者皮肤荧光(SAF)-AGE(SAF-AGEs×年龄/100)与骨密度降低(LBD)/骨质疏松症或主要骨质疏松性骨折(MOFs)之间的关系。
该研究嵌套于前瞻性 REACTION(中国糖尿病个体癌症风险评估)研究中,纳入了 1214 名符合条件的参与者。SAF 用于测量皮肤 AGE(SAF-AGEs)。通过面对面的临床随访确定骨折事件。采用二元逻辑回归分析、线性回归分析和受限立方样条嵌套逻辑模型来检验结果。
在中老年 T2DM 患者中,LBD/骨质疏松症的总体患病率为 35.7%(n=434),MOFs 的总体发生率为 10.5%(n=116)。逻辑分析显示,SAF-AGE 的四分位间距与 LBD/骨质疏松症的风险呈显著正相关(调整多变量后的比值比 [OR] 2.02,95%置信区间 [CI] 1.34-3.03;OR 3.63,CI 2.44-5.39;OR 6.51,CI 4.34-9.78)。SAF-AGE 与 MOFs 相关,调整多变量后的 OR 分别为 1.02(CI 0.52-2.02)、2.42(CI 1.32-4.46)和 2.70(CI 1.48-4.91)。分层分析显示,SAF-AGE 仅与女性、不吸烟者、不饮酒者、BMI 较低者和无 LBD/骨质疏松症者的 MOFs 显著相关。线性回归分析显示,较高的 SAF-AGE 与血清Ⅰ型前胶原氨基端肽(s-PINP)和血清Ⅰ型胶原羧基端交联肽(s-CTX)水平呈正相关,调整多变量后的 OR 分别为 1.02(CI 0.24-1.80)和 6.30(CI 1.77-10.83)。
总之,SAF-AGE 与 T2DM 患者的 LBD/骨质疏松症或 MOFs 患病率呈正相关。还发现 SAF-AGEs 与 s-PINP 和 s-CTX 水平呈正相关。